David R. Okada

Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography.

OBJECTIVES This study sought to determine the feasibility of performing a comprehensive cardiac computed tomographic (CT) examination incorporating stress and rest myocardial perfusion imaging together with coronary computed tomography angiography (CTA). BACKGROUND Although cardiac CT can identify coronary stenosis, very little data exist on the ability to detect stress-induced myocardial perfusion defects in humans. METHODS Thirty-four patients who had a nuclear stress test and invasive angiography were included in the study. Dual-source computed tomography (DSCT) was performed as follows: 1) stress CT: contrast-enhanced scan during adenosine infusion; 2) rest CT: contrast-enhanced scan using prospective triggering; and 3) delayed scan: acquired 7 min after rest CT. Images for CTA, computed tomography perfusion (CTP), and single-photon emission computed tomography (SPECT) were each read by 2 independent blinded readers. RESULTS The DSCT protocol was successfully completed for 33 of 34 subjects (average age 61.4 +/- 10.7 years; 82% male; body mass index 30.4 +/- 5 kg/m(2)) with an average radiation dose of 12.7 mSv. On a per-vessel basis, CTP alone had a sensitivity of 79% and a specificity of 80% for the detection of stenosis > or =50%, whereas SPECT myocardial perfusion imaging had a sensitivity of 67% and a specificity of 83%. For the detection of vessels with > or =50% stenosis with a corresponding SPECT perfusion abnormality, CTP had a sensitivity of 93% and a specificity of 74%. The CTA during adenosine infusion had a per-vessel sensitivity of 96%, specificity of 73%, and negative predictive value of 98% for the detection of stenosis > or =70%. CONCLUSIONS Adenosine stress CT can identify stress-induced myocardial perfusion defects with diagnostic accuracy comparable to SPECT, with similar radiation dose and with the advantage of providing information on coronary stenosis.

Incremental value of adenosine-induced stress myocardial perfusion imaging with dual-source CT at cardiac CT angiography.

PURPOSE First, to assess the feasibility of a protocol involving stress-induced perfusion evaluated at computed tomography (CT) combined with cardiac CT angiography in a single examination and second, to assess the incremental value of perfusion imaging over cardiac CT angiography in a dual-source technique for the detection of obstructive coronary artery disease (CAD) in a high-risk population. MATERIALS AND METHODS Institutional review board approval and informed patient consent were obtained before patient enrollment in the study. The study was HIPAA compliant. Thirty-five patients at high risk for CAD were prospectively enrolled for evaluation of the feasibility of CT perfusion imaging. All patients underwent retrospectively electrocardiographically gated (helical) adenosine stress CT perfusion imaging followed by prospectively electrocardiographically gated (axial) rest myocardial CT perfusion imaging. Analysis was performed in three steps: (a)Coronary arterial stenoses were scored for severity and reader confidence at cardiac CT angiography, (b)myocardial perfusion defects were identified and scored for severity and reversibility at CT perfusion imaging, and (c)coronary stenosis severity was reclassified according to perfusion findings at combined cardiac CT angiography and CT perfusion imaging. The sensitivity, specificity, negative predictive value (NPV), and positive predictive value (PPV) of cardiac CT angiography before and after CT perfusion analysis were calculated. RESULTS With use of a reference standard of greater than 50% stenosis at invasive angiography, all parameters of diagnostic accuracy increased after CT perfusion analysis: Sensitivity increased from 83% to 91%; specificity, from 71% to 91%; PPV, from 66% to 86%; and NPV, from 87% to 93%. The area under the receiver operating characteristic curve increased significantly, from 0.77 to 0.90 (P < .005). CONCLUSION A combination protocol involving adenosine perfusion CT imaging and cardiac CT angiography in a dual-source technique is feasible, and CT perfusion adds incremental value to cardiac CT angiography in the detection of significant CAD.

Cardiac myocardial perfusion imaging using dual source computed tomography

The ability to simultaneously visualize both coronary atherosclerosis and myocardial perfusion may enable the assessment of the anatomical burden and physiological significance of coronary lesions in a single exam. In this paper we introduce a novel use of the dual source CT: pharmacologically induced stress myocardial perfusion imaging, (SP-DSCT). We describe an experimental protocol by which we used the DSCT to assess both stress and rest myocardial perfusion in order to identify areas of infarcted and ischemic myocardium. Based on our initial investigations, this protocol is feasible and can be used to identify hemodynamically significant stenosis. Nevertheless, further studies are required to determine the incremental value of this technique to traditional coronary CT angiography and/or nuclear stress myocardial perfusion imaging.

Isolated cardiac sarcoidosis: A focused review of an under-recognized entity

There is accumulating evidence for the existence of a phenotype of isolated cardiac sarcoidosis (ICS), or sarcoidosis that only involves the heart. In the absence of biopsy-confirmed cardiac sarcoidosis (CS), existing diagnostic criteria require the presence of extra-cardiac sarcoidosis as an inclusion criterion for the diagnosis of CS. Consequently, in the absence of a positive endomyocardial biopsy, ICS is not diagnosable by current guidelines. Therefore, there is uncertainty regarding the epidemiology, pathobiology, clinical characteristics, prognosis, and optimal treatment of ICS. This review will summarize the available data related to the prevalence and prognosis of ICS and will discuss challenges surrounding the diagnosis and management of this under-recognized entity.

Giant Left Circumflex Coronary Artery Aneurysm With Arteriovenous Fistula to the Coronary Sinus

An 80-year-old woman with a history of breast cancer status post radiation therapy, paroxysmal atrial fibrillation, and congestive heart failure was referred to our institution for evaluation of a giant left circumflex (LCx) coronary artery aneurysm with fistulous communication to the coronary sinus. The patient initially presented with shortness of breath and non-ST elevation myocardial infarction associated with anterolateral T-wave inversion on ECG (Figure 1). Chest radiography showed a dense structure with a circular silhouette at the projection of the superior right mediastinum at the location of the right atrium in the posterior-anterior view and in the posterior mediastinum in the lateral view (Figure 2). She underwent cardiac catheterization, which showed no significant obstructive epicardial coronary artery disease. However, the angiogram revealed a large LCx coronary artery aneurysm with fistulous communication to the coronary sinus (Figure 3A and 3B; online-only Data Supplement Movies I and II). To better define the anatomic relationship of this aneurysm, a contrast-enhanced 64-slice multidetector computed tomography (MDCT) was performed. The location of the aneurysm was noted to be posterior to the left ventricle in juxtaposition with the left atrium, and its size measured 6.0 cm × 5.6 cm …

Ultra low radiation dose cardiac CT.

A 36 year old woman with a history of prior tobacco use and body mass index of 20.0 kg/m was referred for a cardiac computed tomography (CT) for evaluation of intermittent atypical chest discomfort which was provoked by exercise and relieved with rest. Given the patients young age an individualized ultra low radiation dose protocol was selected. Using the dual-source CT scanner (Siemens Definition; 2×32× .6) the following parameters were used: prospective triggering at 65% of the R–R interval, 80 kV, 140 mA s. Beta blockers were administered and the average heart rate during the acquisition was 56 beats/minute. The CT demonstrated that all 3 coronary arteries were free of coronary artery disease and had a normal origin from the aortic root (Figs. 1 and 2). The effective radiation dose for the entire study was 0.7 mS v (0.2 mS v for the test bolus and 0.5 mS v for the coronary scan). To the best of our knowledge, this is the lowest reported radiation dose associated with a cardiac CT examination.

Complementary Value of Cardiac Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography in the Assessment of Cardiac SarcoidosisCLINICAL PERSPECTIVE

Background— Although cardiac magnetic resonance (CMR) and positron emission tomography (PET) detect different pathological attributes of cardiac sarcoidosis (CS), the complementary value of these tests has not been evaluated. Our objective was to determine the value of combining CMR and PET in assessing the likelihood of CS and guiding patient management. Methods and Results— In this retrospective study, we included 107 consecutive patients referred for evaluation of CS by both CMR and PET. Two experienced readers blinded to all clinical data reviewed CMR and PET images and categorized the likelihood of CS as no (<10%), possible (10%–50%), probable (50%–90%), or highly probable(>90%) based on predefined criteria. Patient management after imaging was assessed for all patients and across categories of increasing CS likelihood. A final clinical diagnosis for each patient was assigned based on a subsequent review of all available imaging, clinical, and pathological data. Among 107 patients (age, 55±11 years; left ventricular ejection fraction, 43±16%), 91 (85%) had late gadolinium enhancement, whereas 82 (76%) had abnormal F18-fluorodeoxyglucose uptake on PET, suggesting active inflammation. Among the 91 patients with positive late gadolinium enhancement, 60 (66%) had abnormal F18-fluorodeoxyglucose uptake. When PET data were added to CMR, 48 (45%) patients were reclassified as having a higher or lower likelihood of CS, most of them (80%) being correctly reclassified when compared with the final diagnosis. Changes in immunosuppressive therapies were significantly more likely among patients with highly probable CS. Conclusions— Among patients with suspected CS, combining CMR and PET provides complementary value for estimating the likelihood of CS and guiding patient management.

A Contemporary Analysis of Heart Transplantation and Bridge-to-Transplant Mechanical Circulatory Support Outcomes in Cardiac Sarcoidosis

BACKGROUND Patients with end-stage cardiomyopathy due to cardiac sarcoidosis (CS) may be referred for mechanical circulatory support (MCS) and heart transplantation (HT). We describe outcomes of patients with CS undergoing HT, focusing on the use of MCS as a bridge to transplant (BTT). METHODS Using the United Network for Organ Sharing Scientific Registry of Transplant Recipients, we identified all adult waitlisted patients and isolated HT recipients from 2006 to 2015. These were divided into those with and without CS and further divided into those who did or did not receive MCS as BTT. Outcomes included 1- and 5-year post-transplantation freedom from mortality and 5-year freedom from primary graft failure. RESULTS Over the study period, 31,528 patients were listed for HT, 148 (0.4%) of whom had CS. Among the CS patients, 34 (23%) received MCS as BTT. 18,348 patients (58%) eventually underwent HT, including 67 (0.4%) with CS, 20 (30%) of whom had received BTT MCS. Compared with non-CS diagnoses, CS patients had similar 1-year (91% vs 90%; log rank P = .88) and 5-year (83% vs 77%; log rank P = .46) freedom from mortality. Survival was also similar between CS BTT and non-CS BTT groups at 1 year (89% vs 89%; log-rank P = .92) and 5 years (72% vs 75%; log-rank P = .77). CONCLUSIONS Survivals after HT were similar between CS and non-CS patients out to 5 years, and were also similar between CS and non-CS BTT cohorts. Both HT and BTT MCS should be considered in patients with CS.

Digital Image Processing for Medical Applications

The history of medical imaging technology is embedded within the history of visual perception itself. Visual perception exists at the multiple interstices of science, ethics, art, and law. As the panorama of how and what humans can see is continually transformed by technical innovation, creative application, and cultural permission, there are concomitant transformations in conceptions of disease, privacy, beauty, and legal evidence. Digital Image Processing for Medical Applications succeeds in mapping out a small but essential region of this ever-shifting landscape, namely the core competencies and practical skills that are required by end-users of digital imaging technology in the health-care fields.

Directional coronary atherectomy: a time for reflection. Should we let it go?

A series of interventional tools have emerged since the advent of percutaneous coronary angioplasty. Several are fundamental and used routinely, while others less favourable have fallen short of mainstream therapy and/or have settled as a niche device. We present an overview of the evolution of directional coronary atherectomy (DCA), a unique device that was originally conceived in 1984 to solve the limitations of balloon angioplasty. Unfortunately, we have witnessed its use fall significantly out of favour due to premature and controversial study results. In many interventional laboratories DCA is no longer available. However, we strongly feel that allowing DCA to join the list of extinct interventional tools would be very unfortunate. We, herein, present a series of complex percutaneous coronary procedures to illustrate the convenience of DCA use as a lesion-specific niche device. Finally, DCA offers a valuable distinct clinical research function as it allows for in vivo pathological coronary tissue examination. In conclusion, we plead for its continued production and use as an interventional niche device for the wellbeing of our patients.